299 related articles for article (PubMed ID: 33972797)
1. Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo.
Dubiella C; Pinch BJ; Koikawa K; Zaidman D; Poon E; Manz TD; Nabet B; He S; Resnick E; Rogel A; Langer EM; Daniel CJ; Seo HS; Chen Y; Adelmant G; Sharifzadeh S; Ficarro SB; Jamin Y; Martins da Costa B; Zimmerman MW; Lian X; Kibe S; Kozono S; Doctor ZM; Browne CM; Yang A; Stoler-Barak L; Shah RB; Vangos NE; Geffken EA; Oren R; Koide E; Sidi S; Shulman Z; Wang C; Marto JA; Dhe-Paganon S; Look T; Zhou XZ; Lu KP; Sears RC; Chesler L; Gray NS; London N
Nat Chem Biol; 2021 Sep; 17(9):954-963. PubMed ID: 33972797
[TBL] [Abstract][Full Text] [Related]
2. An irreversible inhibitor of peptidyl-prolyl cis/trans isomerase Pin1 and evaluation of cytotoxicity.
Ieda N; Itoh K; Inoue Y; Izumiya Y; Kawaguchi M; Miyata N; Nakagawa H
Bioorg Med Chem Lett; 2019 Feb; 29(3):353-356. PubMed ID: 30585173
[TBL] [Abstract][Full Text] [Related]
3. Identification of a potent and selective covalent Pin1 inhibitor.
Pinch BJ; Doctor ZM; Nabet B; Browne CM; Seo HS; Mohardt ML; Kozono S; Lian X; Manz TD; Chun Y; Kibe S; Zaidman D; Daitchman D; Yeoh ZC; Vangos NE; Geffken EA; Tan L; Ficarro SB; London N; Marto JA; Buratowski S; Dhe-Paganon S; Zhou XZ; Lu KP; Gray NS
Nat Chem Biol; 2020 Sep; 16(9):979-987. PubMed ID: 32483379
[TBL] [Abstract][Full Text] [Related]
4. Computational and Structure-Based Development of High Potent Cell-Active Covalent Inhibitor Targeting the Peptidyl-Prolyl Isomerase NIMA-Interacting-1 (Pin1).
Liu L; Zhu R; Li J; Pei Y; Wang S; Xu P; Wang M; Wen Y; Zhang H; Du D; Ding H; Jiang H; Chen K; Zhou B; Yu L; Luo C
J Med Chem; 2022 Feb; 65(3):2174-2190. PubMed ID: 35089030
[TBL] [Abstract][Full Text] [Related]
5. New PIN1 inhibitors identified through a pharmacophore-driven, hierarchical consensus docking strategy.
Poli G; Di Stefano M; Estevez JA; Minutolo F; Granchi C; Giordano A; Parisi S; Mauceri M; Canzonieri V; Macchia M; Caligiuri I; Tuccinardi T; Rizzolio F
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):145-150. PubMed ID: 34894990
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a Prenylated Flavonol Derivative as a Pin1 Inhibitor to Suppress Hepatocellular Carcinoma by Modulating MicroRNA Biogenesis.
Zheng Y; Pu W; Li J; Shen X; Zhou Q; Fan X; Yang SY; Yu Y; Chen Q; Wang C; Wu X; Peng Y
Chem Asian J; 2019 Jan; 14(1):130-134. PubMed ID: 30474357
[TBL] [Abstract][Full Text] [Related]
7. A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action.
Campaner E; Rustighi A; Zannini A; Cristiani A; Piazza S; Ciani Y; Kalid O; Golan G; Baloglu E; Shacham S; Valsasina B; Cucchi U; Pippione AC; Lolli ML; Giabbai B; Storici P; Carloni P; Rossetti G; Benvenuti F; Bello E; D'Incalci M; Cappuzzello E; Rosato A; Del Sal G
Nat Commun; 2017 Jun; 8():15772. PubMed ID: 28598431
[TBL] [Abstract][Full Text] [Related]
8. Discovery of 4,6-bis(benzyloxy)-3-phenylbenzofuran as a novel Pin1 inhibitor to suppress hepatocellular carcinoma via upregulating microRNA biogenesis.
Fan X; He H; Li J; Luo G; Zheng Y; Zhou JK; He J; Pu W; Zhao Y
Bioorg Med Chem; 2019 Jun; 27(11):2235-2244. PubMed ID: 31027708
[TBL] [Abstract][Full Text] [Related]
9. Conjugates of 18β-glycyrrhetinic acid derivatives with 3-(1H-benzo[d]imidazol-2-yl)propanoic acid as Pin1 inhibitors displaying anti-prostate cancer ability.
Li K; Ma T; Cai J; Huang M; Guo H; Zhou D; Luan S; Yang J; Liu D; Jing Y; Zhao L
Bioorg Med Chem; 2017 Oct; 25(20):5441-5451. PubMed ID: 28838831
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of novel thiazole-based derivatives as human Pin1 inhibitors.
Du L; Wang X; Cui G; Xu B
Bioorg Med Chem; 2021 Jan; 29():115878. PubMed ID: 33246256
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Pin1 inhibitory activity of thiazole derivatives.
Zhao H; Cui G; Jin J; Chen X; Xu B
Bioorg Med Chem; 2016 Nov; 24(22):5911-5920. PubMed ID: 27692510
[TBL] [Abstract][Full Text] [Related]
12. The role of Pin1 in the development and treatment of cancer.
Min SH; Zhou XZ; Lu KP
Arch Pharm Res; 2016 Dec; 39(12):1609-1620. PubMed ID: 27572155
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, state-of-the-art NMR-binding and molecular modeling study of new benzimidazole core derivatives as Pin1 inhibitors: Targeting breast cancer.
Nashaat S; Henen MA; El-Messery SM; Eisa H
Bioorg Med Chem; 2020 Jun; 28(11):115495. PubMed ID: 32307260
[TBL] [Abstract][Full Text] [Related]
14. Prolyl isomerase Pin1 in metabolic reprogramming of cancer cells.
Nakatsu Y; Yamamotoya T; Ueda K; Ono H; Inoue MK; Matsunaga Y; Kushiyama A; Sakoda H; Fujishiro M; Matsubara A; Asano T
Cancer Lett; 2020 Feb; 470():106-114. PubMed ID: 31678165
[TBL] [Abstract][Full Text] [Related]
15. PIN1 Maintains Redox Balance via the c-Myc/NRF2 Axis to Counteract Kras-Induced Mitochondrial Respiratory Injury in Pancreatic Cancer Cells.
Liang C; Shi S; Liu M; Qin Y; Meng Q; Hua J; Ji S; Zhang Y; Yang J; Xu J; Ni Q; Li M; Yu X
Cancer Res; 2019 Jan; 79(1):133-145. PubMed ID: 30355620
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of benzimidazole derivatives as novel human Pin1 inhibitors.
Ma T; Huang M; Li A; Zhao F; Li D; Liu D; Zhao L
Bioorg Med Chem Lett; 2019 Jul; 29(14):1859-1863. PubMed ID: 31103446
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of PIN1 Enhances Cancer Growth and Aggressiveness with Cyclin D1 Induction in EBV-Associated Nasopharyngeal Carcinoma.
Xu M; Cheung CC; Chow C; Lun SW; Cheung ST; Lo KW
PLoS One; 2016; 11(6):e0156833. PubMed ID: 27258148
[TBL] [Abstract][Full Text] [Related]
18. Discovery of novel selenium derivatives as Pin1 inhibitors by high-throughput screening.
Subedi A; Shimizu T; Ryo A; Sanada E; Watanabe N; Osada H
Biochem Biophys Res Commun; 2016 Jun; 474(3):528-533. PubMed ID: 27120460
[TBL] [Abstract][Full Text] [Related]
19. Pin1 is required for sustained B cell proliferation upon oncogenic activation of Myc.
D'Artista L; Bisso A; Piontini A; Doni M; Verrecchia A; Kress TR; Morelli MJ; Del Sal G; Amati B; Campaner S
Oncotarget; 2016 Apr; 7(16):21786-98. PubMed ID: 26943576
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of pyrimidine derivatives as novel human Pin1 inhibitors.
Cui G; Jin J; Chen H; Cao R; Chen X; Xu B
Bioorg Med Chem; 2018 May; 26(8):2186-2197. PubMed ID: 29576270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]